Beta Bionics (BBNX) Competitors $15.56 -0.28 (-1.77%) As of 05/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. ENOV, NVCR, SSII, LMAT, CNMD, WRBY, LQDA, TNDM, EYE, and CDREShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Enovis (ENOV), NovoCure (NVCR), SS Innovations International (SSII), LeMaitre Vascular (LMAT), CONMED (CNMD), Warby Parker (WRBY), Liquidia (LQDA), Tandem Diabetes Care (TNDM), National Vision (EYE), and Cadre (CDRE). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Enovis NovoCure SS Innovations International LeMaitre Vascular CONMED Warby Parker Liquidia Tandem Diabetes Care National Vision Cadre Beta Bionics (NASDAQ:BBNX) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations. Which has better earnings & valuation, BBNX or ENOV? Beta Bionics has higher earnings, but lower revenue than Enovis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$69.83M9.66N/AN/AN/AEnovis$2.15B0.86-$33.26M-$13.95-2.32 Does the MarketBeat Community prefer BBNX or ENOV? Enovis received 29 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 66.67% of users gave Beta Bionics an outperform vote while only 66.04% of users gave Enovis an outperform vote. CompanyUnderperformOutperformBeta BionicsOutperform Votes666.67% Underperform Votes333.33% EnovisOutperform Votes3566.04% Underperform Votes1833.96% Do analysts recommend BBNX or ENOV? Beta Bionics currently has a consensus price target of $24.83, indicating a potential upside of 59.60%. Enovis has a consensus price target of $58.00, indicating a potential upside of 78.95%. Given Enovis' stronger consensus rating and higher probable upside, analysts plainly believe Enovis is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78Enovis 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the media refer more to BBNX or ENOV? In the previous week, Enovis had 8 more articles in the media than Beta Bionics. MarketBeat recorded 8 mentions for Enovis and 0 mentions for Beta Bionics. Enovis' average media sentiment score of 1.10 beat Beta Bionics' score of 0.00 indicating that Enovis is being referred to more favorably in the news media. Company Overall Sentiment Beta Bionics Neutral Enovis Positive Do institutionals and insiders believe in BBNX or ENOV? 98.4% of Enovis shares are held by institutional investors. 2.7% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is BBNX or ENOV more profitable? Beta Bionics has a net margin of 0.00% compared to Enovis' net margin of -5.95%. Enovis' return on equity of 4.39% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Enovis -5.95%4.39%2.80% SummaryEnovis beats Beta Bionics on 10 of the 15 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$674.62M$4.49B$5.37B$8.39BDividend YieldN/A43.63%5.22%4.10%P/E RatioN/A29.4326.8419.71Price / Sales9.6667.72392.34117.39Price / CashN/A51.0838.2534.62Price / BookN/A6.236.794.50Net IncomeN/A$68.16M$3.23B$248.18M7 Day Performance21.18%18.33%4.07%1.14%1 Month Performance54.83%23.04%12.52%15.20%1 Year PerformanceN/A20.61%16.83%6.56% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$15.56-1.8%$24.83+59.6%N/A$674.62M$69.83M0.00294Gap DownENOVEnovis3.1868 of 5 stars$35.86-1.0%$58.00+61.7%-35.7%$2.07B$2.15B-16.376,800Positive NewsNVCRNovoCure3.6348 of 5 stars$17.59+2.9%$32.83+86.7%-22.0%$1.96B$621.71M-12.561,320Positive NewsSSIISS Innovations InternationalN/A$9.95-1.0%N/AN/A$1.93B$20.65M0.004High Trading VolumeLMATLeMaitre Vascular2.5985 of 5 stars$83.30+0.4%$98.14+17.8%+3.5%$1.88B$226.26M45.52490Insider TradeCNMDCONMED4.1173 of 5 stars$59.65+1.8%$62.20+4.3%-23.3%$1.85B$1.32B14.074,100Positive NewsDividend AnnouncementWRBYWarby Parker3.1259 of 5 stars$17.58+0.6%$22.00+25.1%+18.8%$1.84B$795.09M-65.113,030Trending NewsAnalyst ForecastLQDALiquidia3.3318 of 5 stars$19.30+3.5%$27.13+40.5%+25.7%$1.65B$14.14M-11.8450Analyst DowngradeTNDMTandem Diabetes Care4.5045 of 5 stars$22.70-0.7%$39.81+75.4%-56.1%$1.51B$982.95M-11.762,600Positive NewsEYENational Vision2.7623 of 5 stars$18.60-0.2%$17.57-5.5%+18.0%$1.47B$1.85B-93.0014,000Positive NewsAnalyst ForecastGap DownCDRECadre3.4745 of 5 stars$35.25+0.7%$37.00+5.0%+5.6%$1.43B$559.81M42.472,240 Related Companies and Tools Related Companies Enovis Competitors NovoCure Competitors SS Innovations International Competitors LeMaitre Vascular Competitors CONMED Competitors Warby Parker Competitors Liquidia Competitors Tandem Diabetes Care Competitors National Vision Competitors Cadre Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBNX Stock Free BBNX Stock Alerts